We serve 1,1,1,3,3-Pentafluorobutane CAS:406-58-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | Clear transparent liquid | Conform |
| Purity | ≥99% | 99.2% |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like 1,1,1,3,3-Pentafluorobutane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HFC-365mfc physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,HFC-365mfc Use and application,1,1,1,3,3-Pentafluorbutan technical grade,usp/ep/jp grade.
Related News: The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs.7-chloro-1-(4-(cyclopropylmethyl)piperazine-1-carbonyl)-5-methyl-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indol-4-one hydrochloride manufacturer In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.3-(heptyloxy)-2,2-bis((hexyloxy)methyl)propan-1-amine supplier The South Korean government is banning entry to all foreign nationals who visited China’s Hubei province in the past 14 days.4-chloro-N-(6-chloro-5-sulfamoyl-2,3-dihydro-indol-1-yl)-3-sulfamoyl-benzamide vendor The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.
